Clinical trial

External Beam and Radioligand Radiotherapy for mCRPC

NCT07354594

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-07-07

PhasePHASE2

Study timeline

Study start (actual)2026-07-07Date precision: day

Registry last updated2026-09-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancer Metastatic Castration-Resistantunresolved

Interventions

External Beam Radiotherapy Delivered Between Cycles of Radioligand RadiotherapyRADIATION

Standard of care 177Lutetium-PSMARADIATION

Sponsors & collaborators

Centre hospitalier de l'Université de Montréal (CHUM)lead sponsor

Varian, a Siemens Healthineers Companycollaborator

Mapped research locations

MontrealQuebec, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07354594 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.